Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 117,130 | 103,747 | 104,031 | 88,845 | 116,680 |
| Cost of Goods | N/A | N/A | N/A | N/A | 897 |
| Gross Profit | 117,130 | 103,747 | 104,031 | 88,845 | 115,783 |
| Operating Expenses | 60,538 | 38,576 | 38,933 | 43,447 | 65,296 |
| Operating Income | 56,592 | 65,171 | 65,098 | 45,398 | 51,384 |
| Interest Expense | 7,951 | 7,841 | 7,732 | 7,626 | 7,521 |
| Other Income | -2,386 | 2,342 | -2,994 | 2,586 | 637 |
| Pre-tax Income | 46,255 | 59,672 | 54,372 | 40,358 | 44,500 |
| Income Tax | 4,881 | 3,827 | -336,931 | 432 | 1,296 |
| Net Income Continuous | 41,374 | 55,845 | 391,303 | 39,926 | 43,204 |
| Net Income | $41,374 | $55,845 | $391,303 | $39,926 | $43,204 |
| EPS Basic Total Ops | 0.25 | 0.34 | 2.42 | 0.25 | 0.27 |
| EPS Basic Continuous Ops | 0.25 | 0.34 | 2.42 | 0.25 | 0.27 |
| EPS Diluted Total Ops | 0.23 | 0.34 | 2.39 | 0.25 | 0.27 |
| EPS Diluted Continuous Ops | 0.24 | 0.34 | 2.39 | 0.25 | 0.27 |
| EBITDA(a) | $56,951 | $65,529 | $65,494 | $45,808 | $51,805 |